Jonathan Mow

Chief Executive Officer at PHASEBIO PHARMACEUTICALS, INC.

61 year

Health Technology

Consumer Services

Profile

Jonathan P.
Mow was the founder of Corus Pharma, Inc., established in 2001, where the titles held included Secretary & VP-Commercial & Business Development from 2001 to 2006.
Current jobs include Chief Executive Officer & Director at PhaseBio Pharmaceuticals, Inc. since 2014, and Chief Executive Officer & Director at Veralox Therapeutics, Inc. since 2023.
Former jobs include Chief Executive Officer at Trefoil Therapeutics, Inc., Director-Worldwide Oncology Marketing at Bristol Myers Squibb Co. from 1995 to 1997, Vice President-Business Development at Amylin Pharmaceuticals, Inc. from 2007 to 2012, and Principal roles at PathoGenesis Corp, Syntex Laboratories, Inc., and Lederle International.
Education history includes undergraduate studies at the University of California, Berkeley, and an MBA from Tepper School of Business.

Jonathan Mow active positions

Companies	Position	Start
PHASEBIO PHARMACEUTICALS, INC.	Chief Executive Officer	01/09/2014
Veralox Therapeutics, Inc. Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company	Chief Executive Officer	20/06/2023

All active positions of Jonathan Mow

Former positions of Jonathan Mow

Companies	Position	End
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Corporate Officer/Principal	-
Corus Pharma, Inc. Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas	Founder	01/01/2006
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/1997
Trefoil Therapeutics, Inc. Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases	Chief Executive Officer	-
Syntex Laboratories, Inc.	Corporate Officer/Principal	-

See the detail of Jonathan Mow's experience

Training of Jonathan Mow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jonathan Mow's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Health Technology
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
PathoGenesis Corp PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases	Health Technology
Corus Pharma, Inc. Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas	Health Technology
PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases	Health Technology
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syntex Laboratories, Inc.
Lederle International
Tepper School of Business Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trefoil Therapeutics, Inc. Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases	Health Technology
Veralox Therapeutics, Inc. Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company	Health Technology